| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 0.0004 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |